Born in 1999, Jonathan Reichl started his medicine study in fall 2018 at Ludwig-Maximilians-University Munich. In 2020 Jonathan Reichl went on to the Technical University Munich do proceed the clinical part of his medicine study. He began his research work at the German Heart Center Munich in 2022. Supervised by PD. Dr. med. Felix Bourier he began with his work on the long-term outcome of pulmonary vein isolation in paroxysmal atrial fibrillation. Jonathan Reichl is now in his final year of studies and will graduate in spring 2026.
Jonathan Reichl is an ambitious trail-runner and likes to spend his time in the mountains of Bavaria and Tyrol.
The long-term outcome of pulmonary vein isolation in paroxysmal atrial fibrillation is significantly influenced by diabetes mellitus in general as well as by an antidiabetic therapy
Event:
ESC Congress 2024
Topic:
Rhythm Control, Catheter Ablation
Session:
Outcomes after catheter ablation for atrial fibrillation: impact of comorbidities and ablation technique